Exhibit 107

 

Calculation of Filing Fee Tables

 

S-1

 

 

 

(Form Type)

 

Adial Pharmaceuticals, Inc.

 

 

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities and Carry Forward Securities

 

    Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		  

Proposed
Maximum
Offering
Price Per

Unit

   Maximum
Aggregate
Offering
Price(1)		   Fee Rate   Amount of
Registration
Fee
Fees to be Paid   —   —     —       —       —       —       —       —  
                                                         
Fees Previously Paid   Equity   Common Stock, $0.001 par value per share(2)(3)     457(o)       —       —       $  11,500,000       $0.00012120     $  1,393.80  
Fees Previously Paid   Equity   Warrants to purchase shares of Common Stock(3)(4)     —       —       —       —       —       —  
Fees Previously Paid   Equity   Shares of Common Stock issuable upon exercise of the Warrants (2)(3)(5)     457(o)       —       —       $ 10,781,250       $0.00012120     $  1,306.69  
                                                         
                                                         
    Total Offering Amounts           $ 22,281,250       $0.00012120     $ 2,700.49  
    Total Fees Previously Paid                           $ 2,700.49  
    Total Fee Offsets                             —  
    Net Fee Due                             —  
                                     
                                     

 

 

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
(3) Includes shares of common stock and warrants that the underwriters have the option to purchase to cover over-allotments, if any.
(4) No fee required pursuant to Rule 457(i).

(5)

 

 

 The Warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of Common Stock. The proposed maximum aggregate public offering price of the shares of Common Stock issuable upon exercise of the Warrants was calculated to be $10,781,250, which is equal to 75% of $14,375,000 (which is 125% of $11,500,000 since each investor will receive a Warrant to purchase 0.75 of one share of Common Stock for each share of Common Stock purchased in this offering).